Cancer Research 09 AM Call for Abstracts  SU2C
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mardor, Y.
Right arrow Articles by Ram, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mardor, Y.
Right arrow Articles by Ram, Z.
[Cancer Research 65, 6858-6863, August 1, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image Monitoring

Yael Mardor1,3, Ofer Rahav4, Yacov Zauberman2, Zvi Lidar4, Aharon Ocherashvilli1, Dianne Daniels1, Yiftach Roth1,5, Stephan E. Maier7, Arie Orenstein1,6 and Zvi Ram4,6

1 Advanced Technology Center, 2 Neurosurgery Department, 3 Sheba Cancer Research Center, Sheba Medical Center, Tel Hashomer, Ramat Gan; 4 Neurosurgery Department, Sourasky Medical Center, Tel Aviv, Israel; 5 School of Physics and Astronomy, 6 Sackler School of Medicine, Tel-Aviv University; and 7 Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Requests for reprints: Yael Mardor, The Advanced Technology Center, Sheba Medical Center, Tel Hashomer, Ramat Gan 52621, Israel. Phone: 972-3-5302993, 972-52-6667274; Fax: 972-3-5303146; E-mail: yael.mardor{at}sheba.health.gov.il.

Convection-enhanced drug delivery (CED) is a novel approach to directly deliver drugs into brain tissue and brain tumors. It is based on delivering a continuous infusion of drugs via intracranial catheters, enabling convective distribution of high drug concentrations over large volumes of the target tissue while avoiding systemic toxicity. Efficient formation of convection depends on various physical and physiologic variables. Previous convection-based clinical trials showed significant diversity in the extent of convection among patients and drugs. Monitoring convection has proven to be an essential, yet difficult task. The current study describes the application of magnetic resonance imaging for immediate assessment of convection efficiency and early assessment of cytotoxic tissue response in a rat brain model. Immediate assessment of infusate distribution was obtained by mixing Gd-diethylenetriaminepentaacetic acid in the infusate prior to infusion. Early assessment of cytotoxic tissue response was obtained by subsequent diffusion-weighted magnetic resonance imaging. In addition, the latter imaging methodologies were used to establish the correlation between CED extent and infusate's viscosity. It was found that low-viscosity infusates tend to backflow along the catheter track, whereas high-viscosity infusates tend to form efficient convection. These results suggest that CED formation and extent may be significantly improved by increasing the infusate's viscosities, thus increasing treatment effects.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
L. Goldberg, A. Ocherashvilli, D. Daniels, D. Last, Z. R. Cohen, G. Tamar, Y. Kloog, and Y. Mardor
Salirasib (farnesyl thiosalicylic acid) for brain tumor treatment: a convection-enhanced drug delivery study in rats
Mol. Cancer Ther., November 1, 2008; 7(11): 3609 - 3616.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
B. Perlstein, Z. Ram, D. Daniels, A. Ocherashvilli, Y. Roth, S. Margel, and Y. Mardor
Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring
Neuro-oncol, April 1, 2008; 10(2): 153 - 161.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Rousseau, C. Boudou, R. F. Barth, J. Balosso, F. Esteve, and H. Elleaume
Enhanced Survival and Cure of F98 Glioma Bearing Rats following Intracerebral Delivery of Carboplatin in Combination with Photon Irradiation
Clin. Cancer Res., September 1, 2007; 13(17): 5195 - 5201.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
W. J. Bodell, A. P. Bodell, and D. D. Giannini
Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI-015 (BCNU-ethanol)
Neuro-oncol, January 1, 2007; 9(1): 12 - 19.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. ter Horst, S. M. Verwijnen, E. Brouwer, R. C. Hoeben, M. de Jong, B. H.C.G.M. de Leeuw, and P. A.E. Sillevis Smitt
Locoregional Delivery of Adenoviral Vectors
J. Nucl. Med., September 1, 2006; 47(9): 1483 - 1489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.